Price Alert

IN8bio Inc. (INAB)

NASDAQ: INAB · Real-Time Price · USD

2.35

-0.05 (-2.08%)

At close: Aug 15, 2025, 3:59 PM

2.29

-2.55%

After-hours: Aug 15, 2025, 06:39 PM EDT

IN8bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.23M	11.89M	11.12M	4M	10.22M	13.02M	21.28M	12.85M	16.99M	10.86M	18.18M	27.65M	25.74M	32.11M	37.02M	40.67M	12M	15.05M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	271K	269K	266K	259K	259K	256K	256K	254K	253K	n/a	252K	252K	252K	251K	251K	n/a	n/a	n/a
Other Long-Term Assets	275K	275K	275K	505K	320K	320K	255K	255K	255K	508K	507K	483K	246K	158K	158K	409K	3.5M	3.27M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	515K	427K	298K	177K	529K	539K	270K	262K	277K	601K	232K	2.01M	1.26M	1.17M	52K	35K	n/a	n/a
Total Current Assets	13.74M	12.72M	12.58M	6.7M	12.68M	15.76M	24.63M	16.55M	19.46M	14.4M	22.23M	29.65M	27M	33.27M	38.98M	43.88M	12.17M	15.37M
Property-Plant & Equipment	5.08M	6.6M	7.83M	8.5M	9.23M	9.22M	8.57M	9.15M	9.74M	9.77M	10.17M	8.12M	3.49M	2.85M	2.83M	2.85M	1.89M	1.78M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	126K	126K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.63M	7.14M	8.37M	9.26M	9.81M	9.79M	9.08M	9.66M	10.25M	10.28M	10.8M	8.73M	3.99M	3.26M	3.24M	3.26M	5.4M	5.05M
Total Assets	19.37M	19.87M	20.94M	15.97M	22.5M	25.55M	33.71M	26.21M	29.72M	24.68M	33.04M	38.38M	30.99M	36.54M	42.22M	47.13M	17.56M	20.42M
Account Payables	379K	575K	389K	1.14M	1.44M	1.41M	924K	748K	585K	870K	2.09M	1.11M	887K	553K	395K	692K	462K	660K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	940K	n/a	n/a	n/a	n/a	1.54M	1.51M	1.5M	1.52M	n/a	1.39M	915K	560K	631K	n/a	628K	174K	174K
Other Current Liabilities	404K	115K	207K	n/a	1.03M	-1.54M	159K	-214K	-670K	422K	71K	868K	269K	-65K	n/a	-154K	806K	1.03M
Total Current Liabilities	1.95M	2.96M	3.08M	3.63M	4.76M	3.84M	5.39M	4.69M	3.78M	3.75M	5.82M	4.9M	2.97M	2.07M	2.26M	2.16M	2.77M	3.06M
Long-Term Debt	2.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.18M	3.04M	3.38M	3.74M	4.12M	4.18M	3.38M	3.76M	4.14M	4.14M	4.49M	3.92M	1.45M	1.64M	1.78M	1.94M	1.13M	1.04M
Total Liabilities	4.13M	5.99M	6.47M	7.38M	8.88M	8.02M	8.77M	8.45M	7.92M	7.89M	10.31M	8.82M	4.42M	3.7M	4.04M	4.1M	3.9M	4.1M
Total Debt	3.12M	4.27M	5.03M	5.47M	5.9M	5.71M	4.89M	5.26M	5.66M	5.53M	5.87M	4.83M	2.01M	2.27M	2.41M	2.56M	1.96M	1.81M
Common Stock	10K	8K	7K	5K	5K	4K	4K	4K	4K	3K	3K	3K	2K	2K	2K	3K	1K	1K
Retained Earnings	-132.3M	-127.21M	-121.66M	-115.5M	-108.41M	-99.78M	-91.22M	-83.62M	-76.45M	-68.74M	-61.21M	-53.41M	-46.02M	-38.84M	-32.69M	-26.84M	-23.45M	-20.4M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	-47.13M	n/a	n/a
Shareholders Equity	15.24M	13.88M	14.48M	8.59M	13.62M	17.53M	24.94M	17.76M	21.8M	16.79M	22.73M	29.56M	26.57M	32.84M	38.18M	43.04M	13.66M	16.32M
Total Investments	271K	269K	266K	259K	259K	256K	256K	254K	253K	n/a	252K	252K	252K	251K	251K	n/a	n/a	n/a